You may qualify if Roundup exposure in the U.S. before February 17, 2026 led to a non-Hodgkin lymphoma diagnosis.
Non-Hodgkin lymphoma is a cancer of the lymph system, and the proposed class also covers exposed people awaiting diagnosis and family representatives. Monsanto proposed the nationwide class settlement on February 17, 2026, to resolve current and future claims through a long-term claims program, according to Bayer's Q1 2026 Legal Risks report. Payment is not yet available because the court has not given final approval.
Official resources:
- Read the official notice from Cornell — Use this primary source to verify the official announcement.
- Read the official notice from Tradingview — Use this primary source to verify the official announcement.
Table of Contents
- Who is included in the proposed class?
- How much could eligible claims receive?
- Where does court approval stand?
- What should you do while claims remain closed?
Who is included in the proposed class?
The proposed class generally includes farmers, landscapers, groundskeepers, gardeners, and others exposed to Roundup or other glyphosate weed killers in the U.S. before February 17, 2026.
Exposure can be from work or home use. Check these core inclusion points, described in class counsel's court-authorized notice reported by EQS: A home gardener with seasonal spraying and a farmworker with repeated field spraying both fall within the exposure definition. Diagnosis timing and exposure proof will matter more than job title.
- U.S. exposure to Roundup or another glyphosate weed killer before February 17, 2026
- Non-Hodgkin lymphoma diagnosis after qualifying exposure for a payment claim
- Exposed without diagnosis for program membership without current payment
- Family representative for a deceased or incapacitated exposed person
How much could eligible claims receive?
Eligible lymphoma claimants may receive $6,000 to $165,000 or more. The amount turns mainly on work versus home exposure, age at diagnosis, and lymphoma type.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
Funding would come from up to $7.25 billion paid over 17 to 21 years. That long funding period means awards would be paid through a claims program, not in one lump distribution to everyone at once.
Where does court approval stand?
The Circuit Court of St. Louis preliminarily approved the King v. Monsanto settlement on March 4, 2026 and held a final-approval hearing September 14, 2026. No final order had been entered, and no class payments can be made until final approval and appeals end, according to TortAdvisor's November 2026 update.
Separately, the U.S. Supreme Court held 7-2 on June 25, 2026 in Monsanto v. Durnell that federal law expressly preempts state failure-to-warn claims seeking a cancer warning beyond the EPA-approved label, according to the Cornell Legal Information Institute syllabus. That ruling concerns warning-label liability, not the proposed settlement's eligibility rules.
What should you do while claims remain closed?
Registration and claims remain closed pending final approval. Do not pay anyone promising faster access to the class fund.
Preserve product purchase records, work logs, spraying dates, medical evaluations, pathology reports, and death or guardianship papers if acting for another person. Keep copies together and watch the official settlement notice channel for registration opening.
You Might Also Like
- Philadelphia Antiepileptic Drug Mass Tort Program: Who Qualifies?
- Social Media Addiction Lawsuit: Who Qualifies to File a Claim?
- What Documents Do You Need to File a Liability Lawsuit?